logo
Clubhouse International Calls for Support in Advancing Mental Health Initiatives

Clubhouse International Calls for Support in Advancing Mental Health Initiatives

02/13/2025, New York, New York // PRODIGY: Feature Story //
Clubhouse International, a New York-based global nonprofit organization, encourages individuals and entities to join its efforts in delivering improved comprehensive mental health support through funding, advocacy, and partnerships. It shares its strategic plan to increase the number of Clubhouses worldwide over the next decade in hopes of proving that no one has to face mental illness alone.
Mental illness, despite being a leading cause of disability worldwide, lamentably receives an inadequate response to this day. Mental health awareness has grown, but creating sustainable solutions remains a challenge. Clubhouses emerge as an appealing option in helping individuals with mental illness regain control of their lives, serving as supportive spaces where they can find belonging, purpose, and opportunity.
Clubhouse International has spent over 30 years building and strengthening a global network of Clubhouses that serve as lifelines for people with mental illness. It employs the Clubhouse Model, which integrates opportunities for employment, education, housing, and wellness within a single supportive environment.
The Clubhouse Model is an evidence-based approach that has demonstrated success in improving outcomes for those with mental illness. Members of accredited Clubhouses experience higher employment rates, fewer hospitalizations, and better overall health compared to those receiving traditional mental health services. Mental health advocates and policymakers have acknowledged the model's effectiveness, urging Clubhouse International to fight for more comprehensive, community-based mental health care.
The nonprofit's efforts are recognized by acclaimed institutions. In 2021, it was honored with the Special Presidential Commendation Award by the American Psychiatric Association (APA), acknowledging the Clubhouse Model as a cost-effective, rights-based approach to recovery. The organization was also awarded the 2022 Pardes Humanitarian Prize in Mental Health by The Brain and Behavior Research Foundation, solidifying its vital role in mental health rehabilitation.
Aware of its massive impact in the space, Clubhouse International's vision is to make Clubhouses as widespread and accessible as local YMCAs. It's investing in infrastructure, partnerships, personnel, and advocacy efforts to turn its dream of ensuring that every community has a safe, supportive space for people with mental illness into reality. However, this ambitious expansion requires substantial funding and collaboration from various sectors. 'We need partners who share our vision and are willing to invest in the future of mental health care,' says Anna Sackett Rountree, Director of Communications.
Clubhouse International has launched the Campaign for Growth to accelerate its expansion. With proper investment, it aims to establish new Clubhouses in underserved regions to ensure greater accessibility and improve training, accreditation, and operational support to maintain high-quality services. Advancing research and data collection and growing advocacy efforts are also included in the roadmap.
The organization prioritizes partnerships across the education, corporate, and healthcare sectors to achieve its goals. One of its most promising initiatives is its collaboration with academic institutions to integrate mental health awareness and support into educational settings. Clubhouse International has partnered with the University of Notre Dame through Active Minds, a student-led advocacy group focused on mental health. This partnership has already built a strong connection between students and local Clubhouses, providing opportunities to young people so they can engage in mental health advocacy.
Several Clubhouses partner with local universities to introduce students to the realities of living with mental illness. For example, one course, 'Recovering from Mental Illness through Work and Community,' immerses students in the Clubhouse Model and encourages them to explore solutions for mental health challenges. 'Programs like these open doors. Some of the students have become psychiatrists, have served on Clubhouse boards, or have contributed to mental health literature,' Anna proudly shares. 'They're now making a real difference in people's lives.' With adequate funding, Clubhouse International would like to formalize the Clubhouse University Connection initiative.
Clubhouse International also engages with corporate partners to expand the Clubhouse Model. Through its Corporate Partners Program, companies can participate in mental health advocacy initiatives, employee education programs, and workplace inclusion efforts. Companies sharing the same vision have already joined, highlighting the initiative's effectiveness.
The nonprofit's efforts in integrating the Clubhouse Model into broader mental health systems are also underway. It's expanding its psychosocial rehabilitation services in South Carolina, demonstrating how Clubhouses can complement traditional medical care.
Ultimately, all of Clubhouse International's efforts are for the people—individuals who deserve dignity, inclusion, and opportunity. Mental illness is still stigmatized, making many people feel unseen or unheard. The organization changes lives by proving that recovery is possible and achievable for everyone. 'We do this work because we believe in the power of community. Mental health is about connection, purpose, and hope, and everyone deserves that,' Anna stresses.
Clubhouse International's Campaign for Growth represents one step forward in the fight for better mental health support. It welcomes funding, investments, and partnerships from individuals, corporations, and institutions that believe in its vision of making mental health recovery accessible to all.
Media Contact

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Exclusive: Zorro clinches $20M Series A for ICHRA health plans
Exclusive: Zorro clinches $20M Series A for ICHRA health plans

Axios

time25 minutes ago

  • Axios

Exclusive: Zorro clinches $20M Series A for ICHRA health plans

Health benefits provider Zorro raised $20 million in Series A funding led by Entrée Capital, CEO Guy Ezekiel tells Axios exclusively. Why it matters: As employers wrestle with rising health plan costs, individual coverage health reimbursement arrangements (ICHRAs) are gaining steam. Driving the news: Launched in 2020, ICHRAs were enabled by a Trump-era rule letting employers reimburse employees tax-free for individual health insurance instead of offering group plans. After a slow start, rule clarifications and compliance tools made them more accessible to midsized employers. Follow the money: Existing backers Pitango and 10D joined the round, which will be used to scale operations and improve support for employers. The Series A brings Zorro to $31.5 million total raised. The company is not yet profitable. How it works: New York City-based Zorro replaces traditional group plans with defined-contribution models. Employers set a budget; employees use Zorro's AI engine to select personalized plans, and brokers get real-time tools to compare group plans versus ICHRA-based options. When it onboards an employer, Zorro asks them to send their benefits roster from the previous year, asks about quality and budget priorities for the upcoming year, and helps predict what benefits employees might want next. Zorro has "several thousand" lives on the platform, per Ezekiel. Between the lines: Zorro's pitch hinges not just on cost control but on its ability to shift complex decision-making from HR to software — claiming that 75% of users enroll without human help. What they're saying: "We're giving the employer a line of sight to how his upcoming year is going to look," says Ezekiel. Reality check: While ICHRAs are gaining traction, they remain a small fraction of the employer market. Zorro's long-term success depends on widespread broker adoption and employee trust in AI-led benefit decisions. State of play: A February Bailey's report predicted the debut of several new ICHRA startups in 2025. Several others have secured recent funding. In April, Thatch raised $40 million in Series B funding led by Index Ventures and Venteur Health Insurance raised a $20 million Series A led by Informed Ventures and American Family Ventures. Remodel Health last December collected more than $100 million in a round led by Oak HC/FT and Hercules Capital.

Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution

Yahoo

time4 hours ago

  • Yahoo

Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution

In the last year, many Cardinal Health, Inc. (NYSE:CAH) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period. While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. The CEO & Director, Jason Hollar, made the biggest insider sale in the last 12 months. That single transaction was for US$8.0m worth of shares at a price of US$109 each. That means that an insider was selling shares at slightly below the current price (US$161). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. We note that the biggest single sale was only 46% of Jason Hollar's holding. Cardinal Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! View our latest analysis for Cardinal Health I will like Cardinal Health better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying. Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Cardinal Health insiders own about US$146m worth of shares (which is 0.4% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders. The fact that there have been no Cardinal Health insider transactions recently certainly doesn't bother us. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Cardinal Health insiders selling. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we found 1 warning sign for Cardinal Health that deserve your attention before buying any shares. If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching
Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching

Yahoo

time4 hours ago

  • Yahoo

Why HCA Healthcare, Inc. (NYSE:HCA) Could Be Worth Watching

Today we're going to take a look at the well-established HCA Healthcare, Inc. (NYSE:HCA). The company's stock saw a decent share price growth of 19% on the NYSE over the last few months. Shareholders may appreciate the recent price jump, but the company still has a way to go before reaching its yearly highs again. With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine HCA Healthcare's valuation and outlook in more detail to determine if there's still a bargain opportunity. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Good news, investors! HCA Healthcare is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that HCA Healthcare's ratio of 15.45x is below its peer average of 20.5x, which indicates the stock is trading at a lower price compared to the Healthcare industry. Although, there may be another chance to buy again in the future. This is because HCA Healthcare's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity. See our latest analysis for HCA Healthcare Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. HCA Healthcare's earnings over the next few years are expected to increase by 23%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? Since HCA is currently below the industry PE ratio, it may be a great time to increase your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current price multiple. Are you a potential investor? If you've been keeping an eye on HCA for a while, now might be the time to make a leap. Its buoyant future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy HCA. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed assessment. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Our analysis shows 3 warning signs for HCA Healthcare (1 is a bit concerning!) and we strongly recommend you look at these before investing. If you are no longer interested in HCA Healthcare, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store